Company:  SELLAS LIFE SCIENCES GROU ... (SLS)
Form Type:  8-K
Filing Date:  11/18/2011 
CIK:  0001390478 
Address:  315 MADISON AVENUE
4TH FLOOR
 
City, State, Zip:  NEW YORK, New York 10017 
Telephone:  (813) 864-4523 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$5.46  
Change: 
0.44 (8.77%)  
Trade Time: 
Apr 25  
Market Cap: 
$35.89M
Trade SLS now with 

© 2018  
Description of Business
On December 29, 2017, we completed the business combination with the privately held Bermuda exempted company, Sellas Life Sciences Group Ltd., or Private SELLAS, in accordance with the terms of the Agreement and Plan of Merger and Reorganization, dated as of August 7, 2017 and amended November 5, 2017, or the Merger Agreement, by and among our company, Sellas Intermediate Holdings I, Inc., Sellas Intermediate Holdings II, Inc., Galena Bermuda Merger Sub, Ltd., and Private SELLAS. We refer to this business combination throughout this annual report on Form 10-K as the Merger. As a result of the Merger, our business is now substantially comprised of the business of Private Sellas, and although we are considered the legal acquiror of Private SELLAS, for accounting purposes, Private SELLAS is considered to have acquired our company in the Merger. Consequently, the Merger is accounted for as a reverse acquisition.
Register and access this filing in:     
  FORM 8-K
    SECTION 3 SECURITIES AND TRADING MARKETS
      Item 3.01 Notice of Delisting or Failure to Satisfy a ...
    SIGNATURES